Abbreviated Company Accounts - JBK MEDICAL LIMITED
Abbreviated Company Accounts - JBK MEDICAL LIMITED
Registered Number 08721399
JBK MEDICAL LIMITED
Abbreviated Accounts
31 December 2015
JBK MEDICAL LIMITED Registered Number 08721399
Abbreviated Balance Sheet as at 31 December 2015
| Notes | 2015 | 2014 | |
|---|---|---|---|
| £ | £ | ||
| Current assets | |||
| Debtors |
|
|
|
| Cash at bank and in hand |
|
|
|
|
|
|
||
| Creditors: amounts falling due within one year |
( |
( |
|
| Net current assets (liabilities) |
|
|
|
| Total assets less current liabilities |
|
|
|
| Total net assets (liabilities) |
|
|
|
| Capital and reserves | |||
| Called up share capital | 2 |
|
|
| Profit and loss account |
|
|
|
| Shareholders' funds |
|
|
|
For the year ending 31 December 2015 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on
And signed on their behalf by:
JBK MEDICAL LIMITED Registered Number 08721399
Notes to the Abbreviated Accounts for the period ended 31 December 2015
1Accounting Policies
Basis of measurement and preparation of accounts
Turnover policy
Other accounting policies
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more, or a right to pay less or to receive more, tax, with the following exceptions:
Provision is made for tax on gains arising from the revaluation (and similar fair value adjustments) of fixed assets, and gains on disposal of fixed assets that have been rolled over into replacement assets, only to the extent that, at the balance sheet date, there is a binding agreement to dispose of the assets concerned. However, no provision is made where, on the basis of all available evidence at the balance sheet date, it is more likely than not that the taxable gain will be rolled over into replacement assets and charged to tax only where the replacement assets are sold;
Provision is made for deferred tax that would arise on remittance of the retained earnings of overseas subsidiaries, associates and joint ventures only to the extent that, at the balance sheet date, dividends have been accrued as receivable;
Deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.
Deferred tax is measured on an undiscounted basis at the tax rates that are expected to apply in the periods in which timing differences reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.
3Transactions with directors
| Name of director receiving advance or credit: | ||
|---|---|---|
| Description of the transaction: | ||
| Balance at 1 January 2015: | £ |
|
| Advances or credits made: | ||
| Advances or credits repaid: | £ |
|
| Balance at 31 December 2015: | £ |
|